Dapagliflozin, an SGLT2 inhibitor, for diabetes.
| Autor: | Hanefeld M; Centre for Clinical Studies, Gesellschaft für Wissens-und Technologietransfer, Technical University Dresden, 01307 Dresden, Germany. hanefeld@gwtonline-zks.de, Forst T |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Lancet (London, England) [Lancet] 2010 Jun 26; Vol. 375 (9733), pp. 2196-8. |
| DOI: | 10.1016/S0140-6736(10)60749-0 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|